Raymond James Financial Services Advisors, Inc. 10x Genomics, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 28,844 shares of TXG stock, worth $334,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,844Holding current value
$334,590% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
332Shares Held
115MCall Options Held
442KPut Options Held
149K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$161 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$144 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$74.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.02MShares$69.8 Million0.04% of portfolio
-
Nikko Asset Management Americas, Inc.6.01MShares$69.7 Million0.74% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.1B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...